QIN Yuan, REN Dong, FAN Yu-fei, LIU Xiao-lin, LI Ding-gang. Primary study of nimotuzumab combined with gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 64-66. DOI: 10.3969/j.issn.1672-2353.2011.09.021
Citation:
|
QIN Yuan, REN Dong, FAN Yu-fei, LIU Xiao-lin, LI Ding-gang. Primary study of nimotuzumab combined with gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 64-66. DOI: 10.3969/j.issn.1672-2353.2011.09.021
|
QIN Yuan, REN Dong, FAN Yu-fei, LIU Xiao-lin, LI Ding-gang. Primary study of nimotuzumab combined with gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 64-66. DOI: 10.3969/j.issn.1672-2353.2011.09.021
Citation:
|
QIN Yuan, REN Dong, FAN Yu-fei, LIU Xiao-lin, LI Ding-gang. Primary study of nimotuzumab combined with gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 64-66. DOI: 10.3969/j.issn.1672-2353.2011.09.021
|